In one line
📌 Q4 delivered a transformational ~162% YoY revenue jump driven by the consolidation of newly-acquired CrudeChem Technologies (US oilfield specialty chemicals); however, blended EBITDA margins compressed sharply as the lower-margin CrudeChem business diluted the legacy textile chemicals profile. PAT more than doubled in Q4 on a lower effective tax rate, while FY26 PAT growth was a modest +14% on +45% revenue growth — clearly reflecting the margin dilution from the strategic pivot into US oilfield chemicals.
📊 Key numbers — Q4FY26 (Consolidated; ₹ Cr)
📌 Revenue from Operations: ₹313.73 Cr (+162% YoY)
📌 Total Revenue (incl. Other Income): ₹323.19 Cr (+154% YoY)
📌 Gross Profit: ₹91.21 Cr (+110% YoY) → margin 29.07% vs 36.22% YoY (compression ~715 bps)
📌 EBITDA (excl. Other Income): ₹43.69 Cr (+105% YoY) → margin 13.93% vs 17.77% YoY (compression ~384 bps)
📌 PBT: ₹48.12 Cr (+82% YoY)
📌 PAT: ₹43.79 Cr (+118% YoY) → margin 13.96% vs 16.81% YoY
📌 Effective Tax Rate: 9.0% in Q4FY26 vs 23.8% in Q4FY25 — drove PAT growth above PBT growth
📌 Basic EPS: ₹0.38 vs ₹1.76 (not directly comparable due to 4:1 bonus issue + 1:2 stock split during FY26)
📈 FY26 Snapshot (Consolidated; ₹ Cr)
📌 Revenue from Operations: ₹772.23 Cr vs ₹533.33 Cr (+44.8% YoY)
📌 Gross Profit: ₹254.86 Cr vs ₹205.71 Cr (+23.9% YoY) → margin 33.00% vs 38.57% (compression ~557 bps)
📌 EBITDA: ₹134.75 Cr vs ₹127.23 Cr (+5.9% YoY) → margin 17.45% vs 23.85% (compression ~640 bps)
📌 PBT: ₹153.03 Cr vs ₹141.24 Cr (+8.4% YoY)
📌 PAT: ₹125.01 Cr vs ₹109.21 Cr (+14.5% YoY) → margin 16.19% vs 20.48%
📌 Basic EPS: ₹1.08 vs ₹9.53 (post 4:1 bonus + 1:2 split; share count expanded ~10x)
🌍 Revenue Mix — Q4 FY26
📌 International: 70.16%
📌 Domestic: 29.84%
📌 Footprint: ~70 countries, 103+ dealers, 44+ technical marketing experts
💼 What moved the quarter
📌 Massive revenue acceleration driven by full-quarter consolidation of CrudeChem Technologies Group (US, 53.33% controlling stake) — adds ~80,000 MTPA capacity in oilfield specialty chemicals.
📌 Domestic business reported healthy growth across textile chemicals and cleaning & hygiene segments.
📌 Management noted successful pass-through of raw material cost inflation (driven by Middle East geopolitical tensions) — protecting blended margins despite volatility.
📌 New US facility capacity was doubled during the quarter to cater to larger oilfield contracts.
📌 Capacity utilisation, execution capabilities and EBITDA margins at CrudeChem reportedly improving under Fineotex management.
⚠️ Why margins compressed despite topline growth
📌 CrudeChem (US oilfield chemicals) operates at structurally lower gross/EBITDA margins than the legacy textile and FMCG/cleaning business — the consolidation is mathematically diluting blended margins.
📌 Q4 Gross margin fell ~715 bps; EBITDA margin fell ~384 bps; PAT margin fell ~285 bps YoY.
📌 FY26 Gross margin fell ~557 bps; EBITDA margin fell ~640 bps; PAT margin fell ~429 bps YoY.
📌 D&A nearly doubled in Q4 to ₹4.40 Cr vs ₹2.01 Cr YoY (acquisition + new capacity).
📌 Employee costs jumped to ₹17.37 Cr in Q4 vs ₹6.55 Cr YoY (CrudeChem team additions).
📌 PAT outpaced PBT growth due to lower ETR — Q4 ETR 9.0% vs 23.8% YoY; FY26 ETR 18.3% vs 22.7% — likely a mix shift to US tax jurisdiction post-acquisition.
💰 Balance Sheet & Treasury (Consolidated; FY26)
📌 Total Assets: ₹1,159.22 Cr vs ₹814.63 Cr (+42% YoY)
📌 Goodwill: ₹73.52 Cr vs ₹6.14 Cr (CrudeChem acquisition goodwill of ~₹67 Cr)
📌 Total Borrowings: ₹8.20 Cr (LT ₹3.82 Cr + ST ₹4.38 Cr) — company remains effectively debt-free post-acquisition
📌 Cash + Bank + Current Investments: ₹73.23 Cr | Non-current Investments: ₹290.43 Cr | Loans: ₹19.32 Cr → Total treasury ~₹383 Cr
📌 Inventories: ₹154.61 Cr vs ₹64.48 Cr (+140% YoY) — consolidation of CrudeChem inventory
📌 Trade Receivables: ₹290.29 Cr vs ₹115.86 Cr (+151% YoY) — working capital expansion with US business
📌 Trade Payables: ₹160.93 Cr vs ₹56.75 Cr (+184% YoY)
🏢 Key corporate events in FY26
📌 Acquired 53.33% controlling stake in CrudeChem Technologies Group — US-based specialty chemical manufacturer of oilfield chemicals with ~80,000 MTPA capacity at Brookshire & Midland (Texas). Marquee clientele includes Halliburton, ExxonMobil, Baker Hughes, SLB, Devon, Ovintiv, NESR.
📌 Bonus issue 4:1 + Stock split 1:2 — share count expanded ~10x, impacting EPS comparability.
📌 Received ₹35.68 Cr from conversion of 75% of outstanding warrants; Promoter exercised 5,00,000 warrants at aggregate ₹17.30 Cr.
📌 Commenced new state-of-the-art 15,000 MTPA manufacturing facility in August 2025.
📌 2nd ICRA Rating Upgrade — Long Term: A+ (Positive); Short Term: A1+ (Positive).
📌 New US facility capacity doubled during Q4 to cater to larger oilfield contracts.
📌 Government approval received for AquaStrike Premium product.
🎯 Strategic positioning & opportunity
📌 US Oil Field Chemical TAM: $11.5 Bn → projected $19.8 Bn by 2035 (5.6% CAGR); Fineotex targets $200+ Mn revenue by 2028 (~5% target market).
📌 India Specialty Textile Chemicals TAM: USD 2.4 Bn (2025) → USD 3.7 Bn by 2034 (4.61% CAGR).
📌 India Cleaning & Hygiene specialty chemicals TAM: USD 2.1 Bn (2024) → USD 4.5 Bn by 2033 (8.9% CAGR).
📌 Beneficiary of EU/UK FTAs (textile zero-duty access, 30-45% UK export growth projected) and US trade cooperation in oilfield specialty chemicals.
📌 Total Group Capacity: ~2,00,000 MTPA across 5 plants (USA 80,000 + Ambernath 76,000 + Mahape 36,500 + Malaysia 6,500).
🔍 Key monitorables
📌 Sustainability of Q4-exit revenue run-rate of ~₹314 Cr (annualised ~₹1,250 Cr) — visibility on CrudeChem order book and execution.
📌 Margin recovery trajectory — can blended EBITDA margin stabilise above 18-20% as CrudeChem ramps and operating leverage kicks in?
📌 Working capital intensity post CrudeChem integration — receivables jumped 151% YoY; days outstanding to be tracked.
📌 Effective tax rate normalisation — Q4 ETR of 9% appears unusually low; sustainability in FY27 to watch.
📌 Capacity utilisation at the new 15,000 MTPA facility and doubled US capacity.
📌 Domestic textile chemicals momentum amid favourable FTA tailwinds (UK, EU).
📌 Conversion of remaining warrants (25% pending).
📌 Crude oil and US oilfield activity cycle — direct demand driver for ~40%+ of consolidated revenue going forward.
